Filing search / Ownership / eFFECTOR Therapeutics, Inc. / Page 10

425

si7qmcwnocz

4 Aug 21

Business combination disclosure

4:23pm

UPLOAD

waazf6thwbjb

4 Aug 21

Letter from SEC

12:00am

425

o6p2dl69t9uc4

22 Jul 21

Business combination disclosure

4:56pm

SEC STAFF

t10jcf

21 Jul 21

SEC staff action: Order

12:00am

S-4/A

q539lf8z

19 Jul 21

Registration of securities issued in business combination transactions (amended)

5:21pm

CORRESP

3rpid9iti3 zh

19 Jul 21

Correspondence with SEC

12:00am

425

i5prlmvqo

16 Jul 21

Business combination disclosure

4:21pm

UPLOAD

gqkx6

13 Jul 21

Letter from SEC

12:00am

425

3c08fdp7

28 Jun 21

Business combination disclosure

4:16pm

425

ekawic89lxbc 8nn

24 Jun 21

Business combination disclosure

5:29pm

S-4

j14 wz3lpmrbhyzt

14 Jun 21

Registration of securities issued in business combination transactions

5:10pm

425

vfdais

14 Jun 21

Business combination disclosure

9:16am

8-K

kdwqcpccw9arta42js

3 Jun 21

Locust Walk Acquisition Corp. Receives Notification of Deficiency from Nasdaq

4:33pm

425

oocx 6om2by1ipd11l

3 Jun 21

Business combination disclosure

4:31pm

10-Q

yxkh72z65w6o

3 Jun 21

Quarterly report

9:27am

8-K

myt 0hqvx75fmvzhn

27 May 21

Gross proceeds expected to include $60 million from a committed PIPE and up to $175 million held in trust

8:27am

425

a42wvk3125pjvnn

27 May 21

Business combination disclosure

8:25am

NT 10-Q

q627qw2ojcg3m32gh0k

18 May 21

Notice of late quarterly filing

4:45pm

10-K

him6yg

29 Mar 21

Annual report

4:18pm

8-K

6fgjtead4l0y zcs

19 Jan 21

Index to Financial Statement

5:00pm